Prices delayed by at least 15 minutes | Prices updated on 02 May 2025, 17.34 BST | Print
Tristel PLC (TSTL)
ORD 1PThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
Tristel PLC is a player in the healthcare platform. The company is a manufacturer of chlorine dioxide chemistry used for the decontamination of medical devices. Its operating segments include three sectors, Hospital medical device decontamination products which are used predominantly for infection control in hospitals; manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates the majority of its revenue from Hospital medical device decontamination.
Address
Fordham Road
Unit 1B, Lynx Business Park, Newmarket
Snailwell
Cambridgeshire
GBR
CB8 7NY
Telephone
+44 1638721500
Major shareholders
| Name | Amount | Holding (%) |
|---|---|---|
| Liontrust Investment Partners LLP | 5,047,658 | 10.58 |
| Charles Stanley Stockbrokers | 4,172,252 | 8.75 |
| Aviva Investors | 3,121,813 | 6.54 |
| Montanaro Asset Management Limited | 2,373,679 | 4.98 |
| Investec Wealth & Investment Limited | 2,293,267 | 4.81 |
| BGF Investment Management Ltd | 2,220,271 | 4.65 |
| Interactive Investor | 2,055,806 | 4.31 |
| Hargreaves Lansdown PLC | 2,032,461 | 4.26 |
| Unicorn Asset Management Ltd | 1,960,329 | 4.11 |
| Rathbones Investment Management | 1,624,352 | 3.41 |
| Danske Bank A/S | 1,521,102 | 3.19 |
Key personnel
| Name | Position |
|---|---|
| Ms. Elizabeth Dixon | Executive Director,Chief Financial Officer |
| Mr. Matthew Giovanni Sassone | Executive Director,Chief Executive Officer |
| Ms. Isabel Josephine Sutherland Napper | Non-Executive Director |
| Mr. Tom Arthur John Jenkins | Non-Executive Director,Senior Independent Non-Executive Director |
| Ms. Caroline Jane Stephens | Non-Executive Director |
Forecast key dates
Previous key dates
Activity analysis
| 2022 Turnover (£) | 2024 Turnover (£) | |
|---|---|---|
| Hospital environmental surface disinfection | 3.18 mn | 3.44 mn |
| Hospital medical device decontamination | 25.42 mn | 36.34 mn |
| Other revenue | 2.52 mn | 2.16 mn |
| Total | 31.12 mn | 41.93 mn |
Geographical analysis
| 2022 Turnover (£) | 2024 Turnover (£) | |
|---|---|---|
| APAC region | 6.98 mn | - |
| Deferred tax assets | 1.49 mn | - |
| Europe | 0.69 mn | - |
| UK | 13.36 mn | - |
| UK & Europe | 22.26 mn | - |
| Worldwide distributors | 5.21 mn | - |
| Australia | - | 3.81 mn |
| Germany | - | 5.85 mn |
| Other Rest of World (ROW ) | - | 4.95 mn |
| UK to UK and Overseas distributors | - | 26.09 mn |
| Western Europe | - | 8.32 mn |
| Total | 50.00 mn | 49.01 mn |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.